Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
C. Cook
Observed names:
Claire Cook,
Claire E Cook,
Claire E. Cook
Institution:
Massachusetts General Hospital
Observed institutions:
Brigham and Women's Hospital,
Harvard University,
University of Padua,
National Center for Complementary and Integrative Health,
Massachusetts General Hospital,
National Institute of Arthritis and Musculoskeletal and Skin Diseases,
University of Lübeck
show all 7
ORCID:
0000-0002-2455-6682
Observed ORCID:
0000-0002-2455-6682
OpenAlex ID:
A5111432454
Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults
2023
·
Zachary S Wallace
, Gandarvaka Miles
, et al.
·
Annals of the Rheumatic Diseases
·
99
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases
2021
·
Claire Cook
, Naomi J. Patel
, et al.
·
Annals of the Rheumatic Diseases
·
81
PDF
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study
2022
·
Michael Di Iorio
, Claire E. Cook
, et al.
·
Seminars in Arthritis and Rheumatism
·
69
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study
2022
·
Grace Qian
, Xiaosong Wang
, et al.
·
The Lancet Rheumatology
·
51
PDF
Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
2022
·
Gabriel Figueroa-Parra
, Emily L Gilbert
, et al.
·
The Lancet Rheumatology
·
49
PDF
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry
2022
·
Jean Liew
, Milena Gianfrancesco
, et al.
·
RMD Open
·
49
PDF
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
2022
·
Naomi J. Patel
, Xiaosong Wang
, et al.
·
Seminars in Arthritis and Rheumatism
·
45
Coronavirus Disease 2019 Outcomes Among Recipients of Anti‐CD20 Monoclonal Antibodies for Immune‐Mediated Diseases: A Comparative Cohort Study
2021
·
Naomi J. Patel
, Kristin M. D'Silva
, et al.
·
ACR Open Rheumatology
·
44
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave
2022
·
Yumeko Kawano
, Naomi J. Patel
, et al.
·
Annals of the Rheumatic Diseases
·
37
PDF
Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study
2021
·
Tiffany Y-T Hsu
, Kristin M D'Silva
, et al.
·
The Lancet Rheumatology
·
34
PDF
Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases
2022
·
Naomi J. Patel
, Claire Cook
, et al.
·
Annals of the Rheumatic Diseases
·
20
PDF
The Association of Illness-related Uncertainty With Mental Health in Systemic Autoimmune Rheumatic Diseases
2022
·
Zachary S. Wallace
, Claire Cook
, et al.
·
The Journal of Rheumatology
·
20
Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases
2023
·
Jonathan D. Herman
, Caroline Atyeo
, et al.
·
Science Translational Medicine
·
19
PDF
The effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study
2024
·
Sebastian E Sattui
, Bohang Jiang
, et al.
·
The Lancet Rheumatology
·
18
Comparative Effectiveness of Rituximab‐ Versus Cyclophosphamide‐Based Remission Induction Strategies in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis for the Risk of Kidney Failure and Mortality
2023
·
Zachary S. Wallace
, Xiaoqing Fu
, et al.
·
Arthritis & Rheumatology
·
18
PDF
The Positive Predictive Value of a Very High Serum IgG4 Concentration for the Diagnosis of IgG4-Related Disease
2022
·
Matthew C. Baker
, Claire Cook
, et al.
·
The Journal of Rheumatology
·
18
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial
2023
·
Jennifer S Hanberg
, Xiaoqing Fu
, et al.
·
The Lancet Rheumatology
·
17
PDF
The effect of achieving serological remission on subsequent risk of relapse, end-stage renal disease and mortality in ANCA-associated vasculitis: a target trial emulation study
2022
·
Gregory McDermott
, Xiaoqing Fu
, et al.
·
Annals of the Rheumatic Diseases
·
17
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study
2023
·
Rathnam K Venkat
, Xiaosong Wang
, et al.
·
Lara D. Veeken
·
15
PDF
Association Between Systemic Vasculitis and Coronary Microvascular Dysfunction in the Absence of Obstructive Coronary Artery Disease
2023
·
Brittany Weber
, Zachary S. Wallace
, et al.
·
Circulation Cardiovascular Imaging
·
13
PDF
Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic
2021
·
Claire Cook
, Huel Cox
, et al.
·
ACR Open Rheumatology
·
13
PDF
Kidney Transplantation and Cardiovascular Events Among Patients With End‐Stage Renal Disease Due to Lupus Nephritis: A Nationwide Cohort Study
2021
·
April Jorge
, Xiaoqing Fu
, et al.
·
Arthritis Care & Research
·
12
Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study
2023
·
Emily N. Kowalski
, Xiaosong Wang
, et al.
·
Seminars in Arthritis and Rheumatism
·
11
Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
2022
·
Kathleen MM Vanni
, Naomi J Patel
, et al.
·
RMD Open
·
10
PDF
The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United States
2024
·
Zachary S Wallace
, Gandarvaka Miles
, et al.
·
Lara D. Veeken
·
9
PDF
Show more works
View as search
Works count:
55
Citation count:
893
H-index:
17
I10-index:
24
Year
Topic
Type